Top Markets
#1 MowCat MowCat +49.00%
#2 Derive Derive +24.64%
#3 Audiera Audiera +23.59%
#4 Geodnet Geodnet +16.67%
#5 aPriori aPriori +14.97%
#6 Cross Cross +14.04%
#7 Biconomy Biconomy +13.72%
#8 Quack AI Quack AI +13.69%
#9 Humanity Humanity +11.92%
#10 Velvet Velvet +11.26%
Coin of the day
MowCat MowCat
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
InhaleRx Limited InhaleRx Limited

InhaleRx Limited

IRX
Pozycja w akcjach #35421
Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is... Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is an Australian company primarily engaged in advancing and bringing to market medical drug delivery systems. The firm also dedicates efforts to developing specialized inhaled drug formulations. A notable product within its portfolio is the Medihale inhaler, a distinctive sealed-pod device engineered for compatibility with its inhaled medications. This entity formerly traded as Lifespot Health Ltd, officially adopting the name InhaleRx Limited in October 2021.
Cena akcji
$0.01657419
Ostatnia synchronizacja: 2026-03-13
Kapitalizacja rynkowa
$3.93M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-31.14%
Kraj
AU
Handel InhaleRx Limited (IRX)

Kategoria

Healthcare
Historia stopy dywidendy dla InhaleRx Limited (IRX)
Stopa dywidendy (TTM) dla InhaleRx Limited (symbol akcji: IRX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla InhaleRx Limited (IRX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
2.23%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
1.03%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
3.69%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US